Europe - Frankfurt Stock Exchange - FRA:ZEG - GB0009895292 - Common Stock
We assign a fundamental rating of 5 out of 10 to ZEG. ZEG was compared to 54 industry peers in the Pharmaceuticals industry. ZEG has an excellent profitability rating, but there are some minor concerns on its financial health. While showing a medium growth rate, ZEG is valued expensive at the moment.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.21% | ||
| ROE | 20.48% | ||
| ROIC | 14.42% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 24.34% | ||
| PM (TTM) | 16.17% | ||
| GM | 81.9% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.61 | ||
| Debt/FCF | 3.41 | ||
| Altman-Z | 5.96 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.88 | ||
| Quick Ratio | 0.69 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.01 | ||
| Fwd PE | 17.57 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 59.22 | ||
| EV/EBITDA | 28.45 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.74% |
ChartMill assigns a fundamental rating of 5 / 10 to ZEG.DE.
ChartMill assigns a valuation rating of 3 / 10 to ASTRAZENECA PLC (ZEG.DE). This can be considered as Overvalued.
ASTRAZENECA PLC (ZEG.DE) has a profitability rating of 7 / 10.
The Price/Earnings (PE) ratio for ASTRAZENECA PLC (ZEG.DE) is 20.01 and the Price/Book (PB) ratio is 12.35.
The Earnings per Share (EPS) of ASTRAZENECA PLC (ZEG.DE) is expected to grow by 11.95% in the next year.